A 12 Week, Open-Label, Safety Trial Of Pregabalin In Patients With Fibromyalgia
A 12 Week, Open-Label, Safety Trial Of Pregabalin In Patients With Fibromyalgia
The main purpose of this protocol is to evaluate the long-term safety of pregabalin in patients who participated in the previous fibromyalgia Study A0081100 and who wish to receive open-label pregabalin therapy.
Inclusion Criteria:
Exclusion Criteria: